TNSN06103A1 - Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication - Google Patents
Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replicationInfo
- Publication number
- TNSN06103A1 TNSN06103A1 TNP2006000103A TNSN06103A TNSN06103A1 TN SN06103 A1 TNSN06103 A1 TN SN06103A1 TN P2006000103 A TNP2006000103 A TN P2006000103A TN SN06103 A TNSN06103 A TN SN06103A TN SN06103 A1 TNSN06103 A1 TN SN06103A1
- Authority
- TN
- Tunisia
- Prior art keywords
- acylsulfonamides
- inhibitors
- methods
- carboxylic acids
- hcv replication
- Prior art date
Links
- 150000001735 carboxylic acids Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000010076 replication Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- 208000019425 cirrhosis of liver Diseases 0.000 abstract 1
- 208000010710 hepatitis C virus infection Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention provides compounds of the general formulas I-IX, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The present invention further provides treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51154103P | 2003-10-14 | 2003-10-14 | |
| PCT/US2004/033970 WO2005037214A2 (en) | 2003-10-14 | 2004-10-13 | Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN06103A1 true TNSN06103A1 (en) | 2007-11-15 |
Family
ID=37579094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2006000103A TNSN06103A1 (en) | 2003-10-14 | 2006-04-04 | Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN1889970B (en) |
| SI (1) | SI1680137T1 (en) |
| TN (1) | TNSN06103A1 (en) |
| ZA (1) | ZA200603610B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3150596A1 (en) * | 2009-02-27 | 2017-04-05 | Janssen Pharmaceuticals, Inc. | Amorphous salt of a macrocyclic inhibitor of hcv |
| KR101781789B1 (en) * | 2010-01-27 | 2017-09-26 | 에이비 파르마 리미티드. | Polyheterocyclic compounds highly potent as hcv inhibitors |
| CN107043405B (en) * | 2016-02-05 | 2021-11-19 | 爱博新药研发(上海)有限公司 | Crystal form of polycyclic heterocyclic compound, preparation method, application and composition thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6608027B1 (en) * | 1999-04-06 | 2003-08-19 | Boehringer Ingelheim (Canada) Ltd | Macrocyclic peptides active against the hepatitis C virus |
-
2004
- 2004-10-13 SI SI200431968T patent/SI1680137T1/en unknown
- 2004-10-13 CN CN2004800354123A patent/CN1889970B/en not_active Expired - Lifetime
-
2006
- 2006-04-04 TN TNP2006000103A patent/TNSN06103A1/en unknown
- 2006-05-08 ZA ZA200603610A patent/ZA200603610B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1889970B (en) | 2012-06-13 |
| CN1889970A (en) | 2007-01-03 |
| SI1680137T1 (en) | 2013-02-28 |
| ZA200603610B (en) | 2007-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY144593A (en) | Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication | |
| EA200601467A1 (en) | MACROCYCLIC COMPOUNDS AS VIRAL REPLICATION INHIBITORS | |
| MY148690A (en) | Novel macrocyclic inhibitors of hepatitis c virus replication | |
| WO2008005511A8 (en) | Novel inhibitors of hepatitis c virus replication | |
| WO2007047146A3 (en) | Inhibitors of viral replication | |
| TN2009000457A1 (en) | Novel macrocyclic inhibitors of hepatitis c virus replication | |
| TN2009000481A1 (en) | Novel peptide inhibitors of hepatitis c virus replication | |
| WO2006039488A3 (en) | Hcv ns3-ns4a protease inhibition | |
| WO2005035525A3 (en) | 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| WO2005007681A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| WO2009142842A3 (en) | Novel macrocyclic inhibitors of hepatitis c virus replication | |
| TW200510391A (en) | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | |
| WO2009134616A3 (en) | Novel inhibitors of hepatitis c virus replication | |
| UA91677C2 (en) | Macrocyclic compounds as inhibitors of hcv replication | |
| TNSN06103A1 (en) | Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication | |
| UA84579C2 (en) | Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hepatitis c virus replication | |
| TW200611905A (en) | Macrocyclic compounds as inhibitors of viral replication | |
| UA95455C2 (en) | Macrocyclic inhibitors of hepatitis c virus replication |